COVID news: Possible annual vaccine, J&J injection, FDA and more
In the United States, more than 81 million people have tested positive for the coronavirus as of Friday, May 6, according to Johns Hopkins University.
To date, more than 996,000 people in the United States have died, including about 3,000 since last week. Worldwide, there have been more than 516 million confirmed cases of COVID-19, including around 2 million new cases in the past week.
Additionally, more than 6.2 million people have died from the virus worldwide. About 219 million people in the United States are fully vaccinated as of April 29 — 66.3% of the population — and nearly 101 million of those people have received their first booster, according to data from the Centers for Disease Control and Prevention.
About 98% of the United States lives in a place with low or medium community level of COVID-19, according to the agency as of May 6. About 2% of Americans reside in an area with a high community level of COVID-19. For them, it is recommended to wear a mask indoors in public.
The CDC reports that the weekly average of COVID-19 cases increased nationwide as of April 27. Cases are 25.2% higher than the previous week’s average, according to the CDC.
The omicron BA.2 subvariant dominated positive US cases for the week ending April 30.
Here’s what happened between May 1 and May 6.
FDA limits use of Johnson & Johnson COVID vaccine on blood clot risks, agency says
Use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been restricted to “certain individuals” due to rare blood clot risks, the US Food and Drug Administration announced Thursday (May 5).
It is now restricted to people 18 and older “for whom other licensed or approved COVID-19 vaccines are not accessible or clinically appropriate,” the FDA statement said. Additionally, those 18 and older can choose to get the J&J vaccine if they “wouldn’t otherwise receive a COVID-19 vaccine.”
Learn more here:
Most parents are hesitant to vaccinate children under 5 against COVID, survey finds
Most parents of children under the age of 5 in the United States say they are hesitant to have their child vaccinated against COVID-19 – if and when a vaccine is authorized for this age group, a new poll has found.
About one in five parents, 18%, would get their young child vaccinated “right away” if it became an option, according to the Kaiser Family Foundation’s Vaccine Monitor survey released May 4. and see” before allowing their child to be vaccinated.
The Pfizer vaccine is currently licensed for ages 5 and older. Meanwhile, the Moderna stunt is permitted for people 18 and older. Johnson & Johnson’s vaccine was restricted to “certain individuals” 18 and older by the Food and Drug Administration on May 5, McClatchy News reported.
“Slightly more than half of parents of children in this age group say they do not have enough information about the safety and effectiveness of vaccines for children under 5,” noted the report. vaccine follow-up survey.
To learn more, keep reading:
Annual COVID shot may be needed as virus becomes ‘new normal’, FDA officials say
An annual COVID-19 vaccine may be needed — much like flu shots are recommended every year — as living with the virus becomes the “new normal,” Food and Drug Administration officials say.
“It will likely circulate around the world for the foreseeable future, taking its place alongside other common respiratory viruses such as influenza,” three FDA officials wrote in an article published in the peer-reviewed journal JAMA on May 2.
As a result, “society is moving toward a new normal that may well include annual COVID-19 vaccination alongside seasonal flu vaccination.”
Keep reading below:
Yes, home COVID test kits expire – but you might want to keep yours. What there is to know
Yes, there are expiration dates for at-home COVID-19 tests, and you should check to see if an unopened test has been sitting on your shelf for a while.
But while the FDA says you shouldn’t use an expired home test, you may want to save any you may have as the coronavirus continues to spread in the United States.
Beware of counterfeit COVID home tests, FDA warns. How to spot a fake
Keep an eye out for counterfeit COVID-19 home tests circulating in the United States, warns the Food and Drug Administration.
The agency said the bogus tests are “distributed or used” nationwide and are misleading because they resemble FDA-authorized tests. There is a risk of false results when using them.
“You may risk unknowingly spreading COVID-19 and delaying or stopping appropriate medical treatment for COVID-19 if you use a counterfeit test,” the FDA said.
Continue reading here:
This story was originally published May 6, 2022 7:13 a.m.